Meda to divest Euromed manufacturing unit

4 December 2015 - Deborah Wilkes

Archived

Meda is divesting Euromed – its business-to-business manufacturer of herbal extracts and natural active substances – to private-equity firm The Riverside Company for €82 million (US$89 million) in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: